Polysomnography (PSG) studies of sleep changes in Alzheimer's disease (AD) have
reported but not fully established the relationship between sleep disturbances and AD. To …

Targeting the amyloid‐β (Aβ) peptide cascade has been at the heart of therapeutic
developments in Alzheimer's disease (AD) research for more than 25 years, yet no …

Sleep disorders are prevalent in Alzheimer's disease (AD) and a major cause of
institutionalization. Like AD pathology, sleep abnormalities can appear years before …

Sleep is essential for human well-being, yet the quality and quantity of sleep reduce as age
advances. Older persons (> 65 years old) are more at risk of disorders accompanied and/or …

The effects of neurodegenerative syndromes extend beyond cognitive function to involve
key physiological processes, including eating and metabolism, autonomic nervous system …

Objective Sleep disturbances are prevalent in human tauopathies yet despite the
importance of sleep, little is known about its relationship with tau pathology. Here, we …

Objective: To contrast the relationships of hormonal eating peptides and hypothalamic
volumes to eating behavior and metabolic changes (body mass index [BMI]) in behavioral …

Sleep disorders appear to be frequent comorbidities in patients with frontotemporal
dementia (FTD). Insomnia and excessive daytime sleepiness commonly occur in patients …

Abstract Models of Tau pathology related to frontotemporal dementia (FTD) are essential to
determine underlying neurodegenerative pathologies and resulting tauopathy relevant …

Objective Our study aimed to explore the associative relationship between
neurodegenerative diseases and sleep disorders. Patients This 15-year retrospective …